Showing results (311-320 of 428) with videos related to

Sort By:
Pageof 43
Journal of Environmental Quality|January 21, 2015
Determining pathogen and indicator levels in class B municipal organic residuals used for land applicationEric R Rhodes, Laura A Boczek, Michael W Ware, et al.
Clinical Science (London, England : 1979)|December 1, 1989
Production of methylguanidine in dogs with acute and chronic renal failureD P Brooks, G R Rhodes, P Woodward, et al.
Neoplasia (New York, N.Y.)|April 8, 2004
ONCOMINE: a cancer microarray database and integrated data-mining platformDaniel R Rhodes, Jianjun Yu, K Shanker, et al.
The Journal of Trauma|December 1, 1981
Nitroprusside and nitroglycerine in patients with posttraumatic pulmonary failureS J Annest, M E Gottlieb, G R Rhodes, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2004
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progressionDaniel R Rhodes, Jianjun Yu, K Shanker, et al.
Antiviral Therapy|May 17, 2007
Molecular assessment of the potential for renal drug interactions between tenofovir and HIV protease inhibitorsTomas Cihlar, Adrian S Ray, Genevieve Laflamme, et al.
Ambio|September 12, 2019
Offsetting impacts of development on biodiversity and ecosystem servicesLaura J Sonter, Ascelin Gordon, Carla Archibald, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|September 25, 2004
A Myo7a mutation cosegregates with stereocilia defects and low-frequency hearing impairmentCharlotte R Rhodes, Ronna Hertzano, Helmut Fuchs, et al.
Molecular Ecology|June 5, 2013
Using multilevel models to identify drivers of landscape-genetic structure among management areasRachael Y Dudaniec, Jonathan R Rhodes, Jessica Worthington Wilmer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 26, 2013
A phase I trial of oral ridaforolimus (AP23573; MK-8669) in combination with bevacizumab for patients with advanced cancersJ Nemunaitis, H S Hochster, S Lustgarten, et al.
Pageof 43